Tumour vaccines: Personal training by vaccination
Nature Reviews Cancer 17, 451 (2017).
doi:10.1038/nrc.2017.61
Author: Ulrike Harjes
Two groups have shown that personalized, neoantigen-based tumour vaccines elicit effective T cell responses in patients with advanced melanoma, leading to favourable clinical outcomes. Combination with checkpoint blockade can be of additional benefit.
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Ulrike Harjes Tags: Research Highlight Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Melanoma | Skin Cancer | Training | Universities & Medical Training | Vaccines